Alberto Güijosa, MD (@alberto_guijosa) 's Twitter Profile
Alberto Güijosa, MD

@alberto_guijosa

Research Fellow @DanaFarber @harvardmed | MD @UPMexico | Former Research Intern at NCI Mexico @incanMX | Aspiring Hem/Onc

ID: 1539752131695083529

linkhttp://www.linkedin.com/in/alberto-guijosa-ramirez calendar_today22-06-2022 23:28:40

201 Tweet

619 Takipçi

623 Takip Edilen

Alberto Güijosa, MD (@alberto_guijosa) 's Twitter Profile Photo

New phase 2 trial of Zanubrutinib + Ixazomib + Dexamethasone in #WaldenstromsMacroglobulinemia shows a promising VGPR+ rate (46%), but median PFS of 40 mo is only slightly better than IDR and lower than current SOC. Will depth translate to durability in time-limited combos for